Cargando…

Intestinal microsporidiosis in Iran: infection in immune-compromised and immunocompetent patients

BACKGROUND AND PURPOSE: Gastroenteritis and the clinical profile caused by Microsporidia, an opportunistic pathogen, may be severe in immunocompromised individuals, especially in AIDS patients. Conventionally, it is necessary to detect the small infective spores in stained smears. However, due to th...

Descripción completa

Detalles Bibliográficos
Autores principales: Nooshadokht, M, Sharifi, I, Mohammadi, MA, Pirestani, M, Afgar, A, Mahootchi, A, Salari, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mazandaran University of Medical Sciences 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747587/
https://www.ncbi.nlm.nih.gov/pubmed/29302628
http://dx.doi.org/10.29252/cmm.3.1.30
_version_ 1783289302250160128
author Nooshadokht, M
Sharifi, I
Mohammadi, MA
Pirestani, M
Afgar, A
Mahootchi, A
Salari, S
author_facet Nooshadokht, M
Sharifi, I
Mohammadi, MA
Pirestani, M
Afgar, A
Mahootchi, A
Salari, S
author_sort Nooshadokht, M
collection PubMed
description BACKGROUND AND PURPOSE: Gastroenteritis and the clinical profile caused by Microsporidia, an opportunistic pathogen, may be severe in immunocompromised individuals, especially in AIDS patients. Conventionally, it is necessary to detect the small infective spores in stained smears. However, due to the limitations of the microscopy-based methods, several DNA-based methods such as polymerase chain reaction (PCR) have recently been developed to enhance diagnosis sensitivity. Therefore, we sought to evaluate the rate of infection in immunocompromised patients as compared with immunocompetent patients in Kerman, Iran. MATERIALS AND METHODS: We collected stool samples of 199 human subjects (116 males and 83 females), aged 1 to 69 years old. They were divided into immunocompromised (i.e., AIDS [n=72] and cancer-positive patients [n=59]) and immunocompetent (n=68) groups. We comparatively examined the fecal materials using the microscopy and PCR methods. RESULTS: The overall prevalence rate of Microsporidia infection was 10.05% (20/199). Entrocytozoon bieneusi was the only species within the Microsporidia genus that was identified in 14.5% (19/131) of the immunocompromised patients and 1.47% (1/68) of the immunocompetent individuals. CONCLUSION: Considering the higher prevalence rate of microsporidiosis in patients with immunodeficiency (10.03%), we suggest performing sensitive and specific techniques such as PCR for the detection of these parasites in immunocompromised patients.
format Online
Article
Text
id pubmed-5747587
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Mazandaran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-57475872018-01-04 Intestinal microsporidiosis in Iran: infection in immune-compromised and immunocompetent patients Nooshadokht, M Sharifi, I Mohammadi, MA Pirestani, M Afgar, A Mahootchi, A Salari, S Curr Med Mycol Original Article BACKGROUND AND PURPOSE: Gastroenteritis and the clinical profile caused by Microsporidia, an opportunistic pathogen, may be severe in immunocompromised individuals, especially in AIDS patients. Conventionally, it is necessary to detect the small infective spores in stained smears. However, due to the limitations of the microscopy-based methods, several DNA-based methods such as polymerase chain reaction (PCR) have recently been developed to enhance diagnosis sensitivity. Therefore, we sought to evaluate the rate of infection in immunocompromised patients as compared with immunocompetent patients in Kerman, Iran. MATERIALS AND METHODS: We collected stool samples of 199 human subjects (116 males and 83 females), aged 1 to 69 years old. They were divided into immunocompromised (i.e., AIDS [n=72] and cancer-positive patients [n=59]) and immunocompetent (n=68) groups. We comparatively examined the fecal materials using the microscopy and PCR methods. RESULTS: The overall prevalence rate of Microsporidia infection was 10.05% (20/199). Entrocytozoon bieneusi was the only species within the Microsporidia genus that was identified in 14.5% (19/131) of the immunocompromised patients and 1.47% (1/68) of the immunocompetent individuals. CONCLUSION: Considering the higher prevalence rate of microsporidiosis in patients with immunodeficiency (10.03%), we suggest performing sensitive and specific techniques such as PCR for the detection of these parasites in immunocompromised patients. Mazandaran University of Medical Sciences 2017-03 /pmc/articles/PMC5747587/ /pubmed/29302628 http://dx.doi.org/10.29252/cmm.3.1.30 Text en © 2017, Published by Mazandaran University of Medical Sciences on behalf of Iranian Society of Medical Mycology and Invasive Fungi Research Center. This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Nooshadokht, M
Sharifi, I
Mohammadi, MA
Pirestani, M
Afgar, A
Mahootchi, A
Salari, S
Intestinal microsporidiosis in Iran: infection in immune-compromised and immunocompetent patients
title Intestinal microsporidiosis in Iran: infection in immune-compromised and immunocompetent patients
title_full Intestinal microsporidiosis in Iran: infection in immune-compromised and immunocompetent patients
title_fullStr Intestinal microsporidiosis in Iran: infection in immune-compromised and immunocompetent patients
title_full_unstemmed Intestinal microsporidiosis in Iran: infection in immune-compromised and immunocompetent patients
title_short Intestinal microsporidiosis in Iran: infection in immune-compromised and immunocompetent patients
title_sort intestinal microsporidiosis in iran: infection in immune-compromised and immunocompetent patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747587/
https://www.ncbi.nlm.nih.gov/pubmed/29302628
http://dx.doi.org/10.29252/cmm.3.1.30
work_keys_str_mv AT nooshadokhtm intestinalmicrosporidiosisiniraninfectioninimmunecompromisedandimmunocompetentpatients
AT sharifii intestinalmicrosporidiosisiniraninfectioninimmunecompromisedandimmunocompetentpatients
AT mohammadima intestinalmicrosporidiosisiniraninfectioninimmunecompromisedandimmunocompetentpatients
AT pirestanim intestinalmicrosporidiosisiniraninfectioninimmunecompromisedandimmunocompetentpatients
AT afgara intestinalmicrosporidiosisiniraninfectioninimmunecompromisedandimmunocompetentpatients
AT mahootchia intestinalmicrosporidiosisiniraninfectioninimmunecompromisedandimmunocompetentpatients
AT salaris intestinalmicrosporidiosisiniraninfectioninimmunecompromisedandimmunocompetentpatients